Sernova Biotherapeutics (FRA:PSH0) EBITDA Margin % : 0.00% (As of Jan. 2025)

Sernova Biotherapeutics EBITDA Margin % Chart

Sernova Biotherapeutics Annual Data
	Trend	Oct15	Oct16	Oct17	Oct18	Oct19	Oct20	Oct21	Oct22	Oct23	Oct24
EBITDA Margin %		Get a 7-Day Free Trial					-	-	-	-	-

Sernova Biotherapeutics Quarterly Data
	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
EBITDA Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Sernova Biotherapeutics's EBITDA Margin %

For the Biotechnology subindustry, Sernova Biotherapeutics's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sernova Biotherapeutics's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sernova Biotherapeutics's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Sernova Biotherapeutics's EBITDA Margin % falls into.

Sernova Biotherapeutics EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Sernova Biotherapeutics's EBITDA Margin % for the fiscal year that ended in Oct. 2024 is calculated as

Sernova Biotherapeutics's EBITDA Margin % for the quarter that ended in Jan. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sernova Biotherapeutics  (FRA:PSH0) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Sernova Biotherapeutics EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Sernova Biotherapeutics's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Sernova Biotherapeutics Business Description